Sorrento Therapeutics Cash on Hand 2008-2020 | SRNE

Sorrento Therapeutics cash on hand from 2008 to 2020. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Sorrento Therapeutics Annual Cash on Hand
(Millions of US $)
2019 $36
2018 $168
2017 $21
2016 $84
2015 $136
2014 $72
2013 $32
2012 $5
2011 $3
2010 $5
2009 $3
2008 $
2007 $0
Sorrento Therapeutics Quarterly Cash on Hand
(Millions of US $)
2020-06-30 $24
2020-03-31 $22
2019-12-31 $36
2019-09-30 $44
2019-06-30 $71
2019-03-31 $101
2018-12-31 $168
2018-09-30 $136
2018-06-30 $47
2018-03-31 $25
2017-12-31 $21
2017-09-30 $39
2017-06-30 $54
2017-03-31 $35
2016-12-31 $84
2016-09-30 $68
2016-06-30 $133
2016-03-31 $67
2015-12-31 $136
2015-09-30 $123
2015-06-30 $52
2015-03-31 $61
2014-12-31 $72
2014-09-30 $44
2014-06-30 $50
2014-03-31 $30
2013-12-31 $32
2013-09-30 $6
2013-06-30 $6
2013-03-31 $10
2012-12-31 $5
2012-09-30 $6
2012-06-30 $8
2012-03-31 $2
2011-12-31 $3
2011-09-30 $2
2011-06-30 $3
2011-03-31 $5
2010-12-31 $5
2010-09-30 $2
2010-06-30 $2
2010-03-31 $3
2009-12-31 $3
2009-09-30 $4
2009-06-30 $0
2009-03-31 $0
2008-12-31
2008-09-30 $0
2008-06-30
2008-03-31 $0
2007-12-31 $0
2007-09-30
2007-06-30
2007-03-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.224B $0.031B
Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and infectious disease. Sorrento Therapeutics, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.754B 15.29
Bristol Myers Squibb (BMY) United States $131.802B 10.15
CSL (CSLLY) Australia $95.523B 0.00
Gilead Sciences (GILD) United States $78.044B 11.24
Vertex Pharmaceuticals (VRTX) United States $68.537B 38.25
Regeneron Pharmaceuticals (REGN) United States $59.310B 22.68
Biogen (BIIB) United States $42.751B 7.32
Illumina (ILMN) United States $41.801B 48.61
Seattle Genetics (SGEN) United States $31.220B 0.00
Moderna (MRNA) United States $25.715B 0.00
BeiGene (BGNE) Cayman Islands $25.002B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.552B 10.23
Genmab (GMAB) Denmark $22.887B 14.46
Genmab (GNMSF) Denmark $21.934B 5.05
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.715B 0.00
Immunomedics (IMMU) United States $19.717B 0.00
Incyte (INCY) United States $18.605B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.553B 36.39
Alnylam Pharmaceuticals (ALNY) United States $15.463B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.077B 68.19
BioNTech SE (BNTX) Germany $14.216B 0.00
Exact Sciences (EXAS) United States $14.162B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.888B 100.76
QIAGEN (QGEN) Netherlands $11.654B 29.58
ARGENX SE-ADR (ARGX) Netherlands $11.426B 0.00
Sarepta Therapeutics (SRPT) United States $10.815B 0.00
Guardant Health (GH) United States $10.579B 0.00
Bio-Techne Corp (TECH) United States $8.954B 61.43
Galapagos (GLPG) Belgium $8.644B 31.32
Ascendis Pharma (ASND) Denmark $7.886B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $7.643B 19.01
Repligen (RGEN) United States $7.347B 116.62
Exelixis (EXEL) United States $7.181B 26.11
Mirati Therapeutics (MRTX) United States $7.172B 0.00
MyoKardia (MYOK) United States $6.891B 0.00
Acceleron Pharma (XLRN) United States $6.291B 0.00
Novavax (NVAX) United States $6.277B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.236B 0.00
Adaptive Biotechnologies (ADPT) United States $6.222B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.088B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.846B 181.11
Emergent Biosolutions (EBS) United States $5.245B 20.78
Blueprint Medicines (BPMC) United States $4.877B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.848B 0.00
Zai Lab (ZLAB) China $4.481B 0.00
China Biologic Products (CBPO) China $4.353B 25.84
Arena Pharmaceuticals (ARNA) United States $4.211B 0.00
Vir Biotechnology (VIR) United States $4.101B 0.00
MorphoSys AG (MOR) Germany $4.040B 52.95
NeoGenomics (NEO) United States $3.871B 1168.33
Legend Biotech (LEGN) United States $3.739B 0.00
Denali Therapeutics (DNLI) United States $3.687B 0.00
Bluebird Bio (BLUE) United States $3.687B 0.00
Amicus Therapeutics (FOLD) United States $3.571B 0.00
Halozyme Therapeutics (HALO) United States $3.527B 0.00
Reata Pharmaceuticals (RETA) United States $3.453B 0.00
Insmed (INSM) United States $3.396B 0.00
Principia Biopharma (PRNB) United States $3.319B 0.00
Global Blood Therapeutics (GBT) United States $3.274B 0.00
Fate Therapeutics (FATE) United States $3.126B 0.00
Twist Bioscience (TWST) United States $2.970B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.708B 0.00
Alkermes (ALKS) Ireland $2.629B 55.10
Inovio Pharmaceuticals (INO) United States $2.575B 0.00
I-Mab (IMAB) China $2.235B 0.00
PHARMA MAR SA (PHMMF) Spain $2.208B 0.00
Mesoblast (MESO) Australia $2.016B 0.00
Zymeworks (ZYME) Canada $2.006B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 21.57
Seres Therapeutics (MCRB) United States $1.926B 0.00
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Editas Medicine (EDIT) United States $1.811B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.798B 0.00
Intra-Cellular Therapies (ITCI) United States $1.764B 0.00
Revance Therapeutics (RVNC) United States $1.696B 0.00
Eidos Therapeutics (EIDX) United States $1.693B 0.00
UniQure (QURE) Netherlands $1.652B 0.00
Cytokineticsorporated (CYTK) United States $1.548B 0.00
Ligand Pharmaceuticals (LGND) United States $1.516B 51.26
Zealand Pharma (ZEAL) Denmark $1.420B 0.00
Amarin (AMRN) Ireland $1.403B 0.00
Viela Bio (VIE) United States $1.394B 0.00
Sangamo Therapeutics (SGMO) United States $1.383B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.362B 0.00
Beam Therapeutics (BEAM) United States $1.350B 0.00
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.311B 0.00
Coherus BioSciences (CHRS) United States $1.286B 7.50
Mersana Therapeutics (MRSN) United States $1.260B 0.00
Intellia Therapeutics (NTLA) United States $1.223B 0.00
Epizyme (EPZM) United States $1.190B 0.00
Arcus Biosciences (RCUS) United States $1.146B 0.00
NGM Biopharmaceuticals (NGM) United States $1.079B 0.00
Compugen (CGEN) Israel $1.061B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.036B 0.00
REGENXBIO (RGNX) United States $1.008B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.008B 0.00
Castle Biosciences (CSTL) United States $0.979B 0.00
Athenex (ATNX) United States $0.965B 0.00
Arvinas (ARVN) United States $0.937B 0.00
Retrophin (RTRX) United States $0.918B 0.00
Heska (HSKA) United States $0.918B 0.00
Alcobra (ARCT) United States $0.914B 0.00
Myriad Genetics (MYGN) United States $0.904B 0.00
Alector (ALEC) United States $0.886B 0.00
Adverum Biotechnologies (ADVM) United States $0.847B 0.00
Vericel (VCEL) United States $0.814B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.811B 0.00
Genetron Holdings (GTH) China $0.804B 0.00
Pliant Therapeutics (PLRX) United States $0.795B 0.00
Morphic Holding (MORF) United States $0.768B 0.00
NantKwest (NK) United States $0.740B 0.00
Cellectis S.A (CLLS) France $0.737B 0.00
Agenus (AGEN) United States $0.723B 0.00
Frequency Therapeutics (FREQ) United States $0.720B 0.00
Protagonist Therapeutics (PTGX) United States $0.715B 0.00
Pharming Group (PHGUF) Netherlands $0.714B 16.29
MiMedx (MDXG) United States $0.700B 0.00
Codexis (CDXS) United States $0.691B 0.00
VBI Vaccines (VBIV) United States $0.673B 0.00
Kadmon Holdings (KDMN) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Cara Therapeutics (CARA) United States $0.625B 0.00
Intrexon (PGEN) United States $0.603B 0.00
Northwest Biotherapeutics (NWBO) United States $0.600B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.560B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.528B 0.00
Geron (GERN) United States $0.522B 0.00
Scholar Rock Holding (SRRK) United States $0.517B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.512B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.512B 4.48
Forte Biosciences (FBRX) United States $0.511B 0.00
Clovis Oncology (CLVS) United States $0.502B 0.00
Albireo Pharma (ALBO) United States $0.488B 0.00
Cel-Sci (CVM) United States $0.482B 0.00
Dynavax Technologies (DVAX) United States $0.473B 0.00
Celldex Therapeutics (CLDX) United States $0.473B 0.00
Anika Therapeutics (ANIK) United States $0.472B 20.65
Aquinox Pharmaceuticals (NLTX) United States $0.469B 0.00
MeiraGTx Holdings (MGTX) United States $0.451B 0.00
Cue Biopharma (CUE) United States $0.449B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.445B 0.00
IVERIC Bio (ISEE) United States $0.440B 0.00
Pfenex (PFNX) United States $0.435B 0.00
Starpharma Holdings (SPHRY) Australia $0.428B 0.00
Kala Pharmaceuticals (KALA) United States $0.422B 0.00
MannKind (MNKD) United States $0.419B 0.00
Syros Pharmaceuticals (SYRS) United States $0.410B 0.00
UROGEN PHARMA (URGN) United States $0.403B 0.00
Prothena (PRTA) Ireland $0.400B 0.00
Amryt Pharma (AMYT) United Kingdom $0.397B 0.00
Avid Bioservices (CDMO) United States $0.396B 0.00
Athersys (ATHX) United States $0.395B 0.00
AnaptysBio (ANAB) United States $0.390B 0.00
BioDelivery Sciences (BDSI) United States $0.388B 27.43
Puma Biotechnology (PBYI) United States $0.382B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.380B 0.00
Sutro Biopharma (STRO) United States $0.370B 0.00
Kamada (KMDA) Israel $0.367B 17.53
PDL BioPharma (PDLI) United States $0.361B 0.00
Trevena (TRVN) United States $0.358B 0.00
Cellular Biomedicine (CBMG) United States $0.356B 0.00
WAVE Life Sciences (WVE) Singapore $0.349B 0.00
AC Immune SA (ACIU) Switzerland $0.348B 0.00
Fortress Biotech (FBIO) United States $0.340B 0.00
Merus (MRUS) Netherlands $0.340B 0.00
IBio (IBIO) United States $0.337B 0.00
ANI Pharmaceuticals (ANIP) United States $0.331B 7.81
Bicycle Therapeutics (BCYC) United Kingdom $0.325B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.312B 0.00
Precision BioSciences (DTIL) United States $0.309B 0.00
CytomX Therapeutics (CTMX) United States $0.303B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.301B 0.00
Innate Pharma S.A (IPHA) France $0.289B 0.00
Prometic Life Sciences (LMNL) Canada $0.267B 0.00
OSMOTICA PHARM (OSMT) United States $0.255B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.253B 0.00
Selecta Biosciences (SELB) United States $0.253B 0.00
Cardiff Oncology (CRDF) United States $0.249B 0.00
Affimed (AFMD) Germany $0.249B 0.00
ChromaDex (CDXC) United States $0.247B 0.00
Arbutus Biopharma (ABUS) United States $0.242B 0.00
Cyclerion Therapeutics (CYCN) United States $0.235B 0.00
Pluristem Therapeutics (PSTI) Israel $0.227B 0.00
NextCure (NXTC) United States $0.226B 0.00
TELA Bio (TELA) United States $0.220B 0.00
HOOKIPA Pharma (HOOK) United States $0.212B 0.00
XOMA (XOMA) United States $0.206B 0.00
Verastem (VSTM) United States $0.205B 0.00
Dyadic (DYAI) United States $0.203B 0.00
Spero Therapeutics (SPRO) United States $0.199B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Aduro Biotech (ADRO) United States $0.185B 0.00
Liquidia Technologies (LQDA) United States $0.183B 0.00
Kindred Biosciences (KIN) United States $0.182B 0.00
Biofrontera AG (BFRA) Germany $0.177B 0.00
ADMA Biologics Inc (ADMA) United States $0.176B 0.00
Theratechnologies (THTX) Canada $0.175B 0.00
DBV Technologies S.A (DBVT) France $0.174B 0.00
Eton Pharmaceuticals (ETON) United States $0.171B 0.00
Cerecor (CERC) United States $0.169B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.167B 0.00
Abeona Therapeutics (ABEO) United States $0.165B 0.00
Checkpoint Therapeutics (CKPT) United States $0.165B 0.00
CorMedix Inc (CRMD) United States $0.163B 0.00
Exicure (XCUR) United States $0.157B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.155B 7.25
Five Prime Therapeutics (FPRX) United States $0.154B 0.00
VolitionRX (VNRX) United States $0.151B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Aptinyx (APTX) United States $0.146B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.146B 0.00
Aytu Bioscience (AYTU) United States $0.145B 0.00
SESEN BIO, INC (SESN) United States $0.144B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.140B 0.00
GENFIT S.A (GNFT) France $0.139B 0.00
AquaBounty Technologies (AQB) United States $0.137B 0.00
Bellus Health (BLU) Canada $0.130B 0.00
Celyad SA (CYAD) Belgium $0.128B 0.00
VTv Therapeutics (VTVT) United States $0.123B 0.00
Cidara Therapeutics (CDTX) United States $0.123B 0.00
Applied Genetic Technologies (AGTC) United States $0.122B 0.00
Protalix BioTherapeutics (PLX) Israel $0.118B 0.00
Strongbridge Biopharma (SBBP) United States $0.117B 0.00
Lumos Pharma (LUMO) United States $0.117B 0.00
Windtree Therapeutics (WINT) United States $0.116B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
Palatin Technologies (PTN) United States $0.108B 2.77
Pieris Pharmaceuticals (PIRS) United States $0.106B 0.00
Orgenesis (ORGS) United States $0.106B 5.37
Gritstone Oncology (GRTS) United States $0.103B 0.00
Enzo Biochem (ENZ) United States $0.100B 0.00
Antibe Therapeutics (ATBPF) Canada $0.098B 0.00
Unum Therapeutics (UMRX) United States $0.098B 0.00
Catalyst Biosciences (CBIO) United States $0.094B 0.00
PHASEBIO PHARMA (PHAS) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.085B 0.00
Oncobiologics (OTLK) United States $0.084B 0.00
Bionano Genomics (BNGO) United States $0.082B 0.00
Evogene (EVGN) Israel $0.080B 0.00
ARAVIVE, INC (ARAV) United States $0.079B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
DiaMedica Therapeutics (DMAC) United States $0.073B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Edesa Biotech (EDSA) Canada $0.070B 0.00
Prima BioMed (IMMP) Australia $0.069B 0.00
Synlogic (SYBX) United States $0.068B 0.00
Clearside Biomedical (CLSD) United States $0.067B 0.00
Adocia (ADOCY) France $0.067B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.067B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.060B 0.00
AmpliPhi Biosciences (ARMP) United States $0.058B 0.00
TRACON Pharmaceuticals (TCON) United States $0.057B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.057B 0.00
Curis (CRIS) United States $0.056B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.055B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
Appili Therapeutics (APLIF) Canada $0.053B 0.00
Emmaus Life Sciences (EMMA) United States $0.052B 0.00
Soligenix (SNGX) United States $0.052B 0.00
AnPac Bio-Medical Science (ANPC) China $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Novogen (KZIA) Australia $0.048B 0.00
Stealth BioTherapeutics (MITO) United States $0.047B 67.00
Cocrystal Pharma (COCP) United States $0.047B 0.00
Happiness Biotech Group (HAPP) China $0.045B 0.00
CollPlant Holdings (CLGN) Israel $0.044B 0.00
Genetic Technologies (GENE) Australia $0.044B 0.00
Organovo Holdings (ONVO) United States $0.042B 0.00
Signal Genetics (MGEN) United States $0.041B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Pulmatrix (PULM) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Vaccinex (VCNX) United States $0.036B 0.00
Chanticleer Holdings (SONN) United States $0.032B 0.00
BioCardia (BCDA) United States $0.030B 0.00
OvaScience (MLND) United States $0.029B 0.00
Prana Biotechnology (ATHE) Australia $0.027B 0.00
Apricus Biosciences (SEEL) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Cleveland BioLabs (CBLI) United States $0.025B 0.00
Advaxis (ADXS) United States $0.024B 0.00
Celsion (CLSN) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Acorda Therapeutics (ACOR) United States $0.023B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.021B 0.00
Cesca Therapeutics (THMO) United States $0.020B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.019B 0.00
Spherix (AIKI) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00